METROPOLIS - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

IntraDay Trade Rating: 3.2

💹 Optimal Buy Price: ₹2,015–₹2,020 (near 50 DMA and short-term support)

🎯 Profit Target: ₹2,045–₹2,060 (minor resistance zone)

🛡️ Stop Loss: ₹2,000 (below 50 DMA and psychological support)

📊 Exit Strategy if Already Holding: Consider exiting near ₹2,055 if RSI approaches 60 and MACD flattens. Watch for volume spikes and price rejection near ₹2,060.

✅ Positive

• 📈 PAT improved to ₹35.6 Cr from ₹23.8 Cr (QoQ)
• 📊 DII holding increased by 0.70%, indicating domestic institutional confidence
• 📉 Trading above both 50 DMA and 200 DMA, suggesting technical support
• 📊 Volume today (83.4K) is above 1-week average (53.4K), showing rising interest
• 📈 EPS of ₹25.1 supports valuation strength

⚠️ Limitation

• 📉 MACD at -14.7 indicates weak short-term momentum
• 📉 RSI at 57.2 is neutral, not strongly bullish
• 📉 High P/E of 81.4 vs industry average of 43.2 suggests overvaluation
• 📉 PEG ratio of -5.83 reflects poor growth-adjusted valuation
• 📉 FII holding declined by 0.31%

🚫 Company Negative News

• 📉 No major negative news reported recently

📢 Company Positive News

• 📈 Quarterly profit growth of 13.8% shows operational improvement
• 📊 Strong volume and technical support near DMA levels

🏭 Industry

• 🧪 METROPOLIS operates in the diagnostics and healthcare services sector, which remains defensive and stable
• 📈 Industry P/E of 43.2 supports long-term valuation potential

🧾 Conclusion

📌 METROPOLIS offers a cautiously optimistic intraday setup today with improving fundamentals and rising volume, but weak momentum indicators and high valuation. Traders may consider entering near ₹2,018 with a target of ₹2,055 and stop loss at ₹2,000. If already holding, monitor RSI and MACD for exit signals near resistance.

I can also help you compare METROPOLIS with other diagnostic stocks like Dr. Lal PathLabs or Thyrocare for stronger intraday setups.